Skip to main content

and
  1. Article

    Open Access

    No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan

    CPT-11 (irinotecan) is a DNA-topoisomerase I inhibitor with preclinical activity against neuroblastoma (NB) xenografts. The aim was to establish in vivo an NB xenograft resistant to CPT-11 in order to study the r...

    L Calvet, A Santos, A Valent, M-J Terrier-Lacombe, P Opolon in British Journal of Cancer (2004)

  2. Article

    Open Access

    Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy

    The aim of this study was to describe the incidence, clinical and histological characteristics, treatment and long-term follow-up of bilateral germ-cell tumours (BGCT) of the testis in order to determine in wh...

    Ch Theodore, M J Terrier-Lacombe, A Laplanche, G Benoit in British Journal of Cancer (2004)

  3. Article

    Open Access

    Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children

    A series of 23 children with primitive neuroectodermal tumours (PNET) were analysed with comparative genomic hybridization (CGH). Multiple chromosomal imbalances have been detected in 20 patients. The most fre...

    H Avet-Loiseau, A-M Vénuat, M-J Terrier-Lacombe in British Journal of Cancer (1999)

  4. Article

    Open Access

    Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

    High-dose busulphan-containing chemotherapy regimens have shown high response rates in children with relapsed or refractory neuroblastoma, Ewing’s sarcoma and medulloblastoma. However, the anti-tumour activity...

    I Boland, G Vassal, J Morizet, M-J Terrier-Lacombe in British Journal of Cancer (1999)